The impact of substitution treatment in prisons-A literature review

International Journal of Drug Policy

Volumn 18, Issue 6, 2007, Pages 464-474

  Stallwitz, Anke ^a   Stöver, Heino ^b  

^a Universität Bremen ^*  (Germany)

^b UNIVERSITY OF BREMEN   (Germany)

Author keywords

Crime prevention; Drug use related risk behaviours; Methadone; Prison; Relapse prevention; Substitution treatment

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BUPRENORPHINE; LOFEXIDINE; METHADONE;

CRIMINAL BEHAVIOR; DRUG ABUSE; DRUG DETOXIFICATION; DRUG USE; HUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; PRISON; PSYCHOSOCIAL CARE; RECIDIVISM; RELAPSE; SHORT SURVEY; SUBSTITUTION THERAPY;

ANALGESICS, OPIOID; CRIME; HEALTH SERVICES ACCESSIBILITY; HUMANS; METHADONE; OPIOID-RELATED DISORDERS; PRISONERS; PRISONS; QUALITY ASSURANCE, HEALTH CARE; RECURRENCE; RISK-TAKING;

EID: 36649028492     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2006.11.015     Document Type: Short Survey

References (88)

1. Allwright S., Bradley F., Long J., Barry J., Thornton L., and Parry J.V. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: Results of a national cross sectional survey. British Medical Journal 321 (2000) 78-82
2. Ball J., and Ross A. The effectiveness of methadone maintenance treatment: Patients, programs, services and outcomes (1991), Springer-Verlag, New York
3. Bellin E., Wesson J., Tomasino V., Nolan J., Glic A.J., and Oquendo S. High dose methadone reduces criminal recidivism in opiate addicts. Addiction Research 7 1 (1999) 19-29
4. Bertram, S. (1991). Results of Gaols Urinalyses Update: July-December 1989. Evaluation of NSW Department of Corrective Services Pre-release Methadone Program. Study No. 10. Research and Statistics Division: NSW Department of Corrective Services.
5. Bertram, S., & Gorta, A. (1990a). Views of recidivists released after participating in the NSW prison methadone program and the problems they faced in the community. Evaluation of the NSW Department of Corrective Services Prison Methadone Program. Study No. 8. Research and Statistics Division: NSW Department of Corrective Services, Publication no. 21.
6. Bertram, S., & Gorta, A. (1990b). Inmates' perceptions of the role of the NSW prison methadone program in preventing the spread of Human Immunodeficiency Virus. Evaluation of NSW Department of Corrective Services Prison Methadone Program. Study No. 9. Research and Statistics Division: NSW Department of Corrective Services.
7. Biernacki P., and Waldorf D. Snowball sampling: Problems and techniques of chain referral sampling. Sociological Methods and Research 10 2 (1981) 141-163
8. Bird S.M., and Hutchinson S.J. Male drugs-related deaths in the fortnight after release from prison: Scotland, 1996-1999. Addiction 98 (2003) 185-190
9. Boguna J. Methadone maintenance programmes. In: O'Brien O. (Ed). Report of the 3rd European conference on drug and HIV/AIDS services in prison 68-70 (1997), Cranstoun Drug Services, London 68-70
10. British Medical Association. The misuse of drugs (1997), Harwood Academic Publishers, Amsterdam
11. Cairns A., Roberts I., and Benbow E.W. Characteristics of fatal methadone overdose in Manchester, 1985-1994. British Medical Journal 313 (1996) 264-265
12. Cooper G.A., Seymour A., Cassidy M.T., and Oliver J.S. A study of methadone in fatalities in the Strathclyde Region, 1991-1996. Medicine, Science and the Law 39 (1999) 233-242
13. Condelli W.S., and Dunteman G.H. Exposure to methadone programs and heroin use. American Journal of Drug and Alcohol Abuse 19 1 (1993) 65-78
14. Council of Europe (Ed.) (1995). Prison and Criminological Aspects of the Control of Transmissible Diseases including AIDS and Related health Problems in Prisons: Recommendation No. R (93) 6 and Explanatory Report. Strasbourg: Council of Europe Press.
15. Council of Europe. Development and improvement of substitution programmes (December 2001), Council of Europe Publishing, Strasbourg
16. Crowley D. The drug detox unit at Mountjoy prison-a review. Journal of Health Gain 3 3 (1999) 17-19
17. Darke S., Kaye S., and Finlay-Jones R. Drug use and injection risk-taking among prison methadone maintenance patients. Addiction 93 8 (1998) 1169-1175
18. Darke S., and Zador D. Fatal heroin overdose: A review. Addiction 91 (1996) 1765-1772
19. Dayman, G. (2006). Prison opioid substitution in South Australia. Six years experience and data. In Abstracts submitted to the international prisoner health conference, Tallinn/Estonia, June 19-20, 2006.
20. Dolan K., Hall W., and Wodak A. Methadone maintenance reduces injecting in prison. British Medical Journal 312 4 (1996) 1162
21. Dolan, K., Shearer, J., White, B., & Wodak, A. (2002). A randomised controlled trial of methadone maintenance treatment in NSW prisons. NDARC Technical Report No. 155.
22. Dolan K.A., Shearer J., White B., Zhou J.L., Kaldor J., and Wodak A.D. Four-year follow-up of imprisoned male heroin users and methadone treatment: Mortality, re-incarceration and hepatitis C infection. Addiction 100 6 (2005) 820-828
23. Dolan K., and Wodak A. An international review of methadone provision in prisons. Addiction Research 4 1 (1996) 85-97
24. Dolan K.A., Wodak A.D., and Hall W.D. Methadone maintenance treatment reduces heroin injection in NSW prisons. Drug & Alcohol Review 17 (1998) 153-158
25. Dyer C. English prison doctor struck off. British Medical Journal 318 7177 (1999) 148
26. EMCDDA (2003). Annual Report 2003. the state of the drugs problem in the acceding and candidate countries to the European Union. Lisbon.
27. EMCDDA (2005). Annual Report 2005. Lisbon.
28. Farrell M., Gowing L., Marsden J., Ling W., and Ali R. Effectiveness of drug dependence treatment in HIV prevention. International Journal of Drug Policy 16 (2005) 67-75
29. Gerstein D., and Harwood H. Treating drug problems. Vol. 1: A study of effectiveness and financing of public and private drug treatment systems (1990), National Academy Press, Washington, DC
30. Gorta, A. (1987). Process evaluation of NSW Department of Corrective Services Pre-release Methadone Program. Study No 3. Research and Statistics Division: NSW Department of Correctional Services.
31. Gorta, A. (1992). Monitoring the NSW prison methadone program: A review of research 1986-1991. Publication No. 25. Research and Statistics Division: NSW Department of Corrective Services.
32. Hannifin, J. (July 30, 1997). Report on the Evaluation of the Protocol for Methadone Treatment Programmes in Prisons. New Zealand: Alcohol & Drug Issues Ltd., Department of corrections.
33. Harding-Pink D. Mortality following release from prison. Medicine, Science and the Law 30 1 (1990) 12-16
34. Hartel D.M., and Schoenbaum E.E. Methadone treatment protects against HIV infection: Two decades of experience in the Bronx, New York City. Public Health Reports 113 Suppl. 1 (1998) 107-115
35. Heimer R., Catania H., Zambiano A., Brunet A., Ortis A.M., and Newman R.G. Methadone maintenance in a men's prison in Puerto Rico: A pilot program. Journal of Correctional Healthcare 11 3 (2005) 295-305
36. Herzog, C., Fasnacht, M., Stohler, & R., Ladewig, D. (1993). Methadone substitution as an AIDS-preventive measure in the prison environment. In Paper presented at the European Symposium Drug Addiction & AIDS, Siena, Italy, October 4-6.
37. HM Inspectorate of Prisons for England and Wales. Patient or prisoner? A new strategy for health care in prisons (discussion paper) (1996), Home Office, London
38. HM Prison Service. Health care standards for prisons in England and Wales (1996), HM Prison Service, London
39. Howells C., Allen S., Gupta J., Stillwell G., Marsden J., and Farrell M. Prison based detoxification for opioid dependence: A randomised double blind controlled trial of lofexidine and methadone. Drug and Alcohol Dependence 67 2 (2002) 169-176
40. Hubbard R.L., Rachal J.V., and Craddock S.G. Treatment outcome prospective study (TOPS): Client characteristics before, during, and after treatment (1984), NIDA, Washington
41. Hughes R.A. 'It's like having half a sugar when you were used to three'-drug injectors' views and experiences of substitute drug prescribing inside English prisons. International Journal of Drug Policy 10 6 (2000) 455-466
42. Hume, S., & Gorta, A. (1988). Views of key personnel involved with the administration of the NSW prison methadone program. Process evaluation of the NSW Department of Corrective Services Prison Methadone Program. Study No 5. Unpublished report. Sydney: Research and Statistics Division, New South Wales Department of Corrective Services.
43. Hume, S., & Gorta, A. (1989). The effects of the NSW prison methadone program on criminal recidivism and retention in methadone treatment. Evaluation of the NSW Department of Corrective Services Prison Methadone Program. Study No 7. Sydney: Research and Statistics Division, New South Wales Department of Corrective Services.
44. Johnson, S. L., van de Veen, J., & Grant, B. (September 2001). Institutional methadone maintenance treatment: Impact on release outcome and institutional behaviour. Addiction Research Centre, Research Branch, Correctional Service Canada.
45. Joseph H., et al. Heroin addicts in jail. New York tries methadone treatment program. Corrections Today 5 (1989) 124-131
46. Joukamaa M. The mortality of released Finnish prisoners: A 7 year follow-up study of the WATTU project. Forensic Science International 96 1 (1998) 11-19
47. Jürgens, R. (2006). Evidence for Action Technical Papers. Effectiveness of Interventions to Manage HIV/AIDS in Prison Settings. WHO, Geneva (unpublished).
48. Kaufmann B., Dobler-Mikola A., and Uchtenhagen A. Kontrollierte Opiatabgabe im schweizerischen Strafvollzug (1998), Bericht ISF, Zuerich
49. Kerr, T., & Jürgens, R. (2004). Methadone maintenance therapy in prisons: Reviewing the evidence. Canadian HIV/AIDS Legal Network. Downloaded on February 8, 2005 from: http://www.aidslaw.ca/Maincontent/issues/prisons/MMT_150604.PDF.
50. Kreek M.J. Methadone-related opioid agonist pharmacotherapy for heroin addiction. History, recent molecular and neurochemical research and future in mainstream medicine. Annals of the New York Academy of Sciences 909 (2000) 186-216
51. Lines, R., & Stöver, H. (2005). HIV/AIDS Prevention, Care, Treatment, and Support in Prison Settings. A Framework for an Effective National Response. For: The United Nations Office on Drugs and Crime (UNODC), Vienna.
52. Magura S., Rosenblum A., Lewis C., and Joseph H. The effectiveness of in-jail methadone maintenance. Journal of Drug Issues (Winter 1993) 75-97
53. Metzger D.S., Navaline H., and Woody G. Drug abuse treatment as AIDS prevention. Public Health Reports 113 (1998) S97-S102
54. Marzo J.N., Levasseur L., Blatier C., and Ross N. Fréquence des réincarcérations dans une même maison d'arrêt: Rôle des traitements de substitution. Annales de Medecine Interne 153 3 (2001) 1S14-1S19
55. Metzger D.S., Navaline H., and Woody G. Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: An 18-month prospective follow-up. Journal of Acquired Immune Deficiency Syndromes 6 9 (1993) 1049-1056
56. Michel, L., & Maguet, O. (2003). L'organisation des soins en matière de traitements de substitution en milieu carcéral. Rapport pour la Commission nationale Consultative des Traitements de Substitution. 1er avril 2003.
57. Mourino A.M. Behandlung mit Ersatzopiaten in einer katalanischen Strafvollzugsanstalt. Seminar "Management of drug addicts in prison". Athens, March 3-5, 1994 (1994)
58. Neale J. Drug users' view of prescribed methadone. Drugs Education Prevention and Policy 5 1 (1998) 33-45
59. Novick D., Joseph H., and Croxson T. Absence of antibody to human immunodeficiency virus in long-term, socially rehabilitated methadone maintenance patients. Archives of Internal Medicine 150 1 (1990) 97-99
60. Palmer J. Clinical management and treatment of substance misuse for women in prison. NHS, Central and North West London (2003), Mental Health NHS Trust, London
61. Pearson F.S., and Lipton D.S. A meta-analytical review of the effectiveness of corrections-based treatments for drug abuse. The Prison Journal 79 4 (1999) 384-410
62. Pont, J., Resinger, E., & Spitzer, B. (2005). Substitutions-Richtlinien für Justizanstalten. Vienna, January 2005 (unpublished guideline on the practice of substitution treatment of the Ministry of Justice of Austria).
63. Reed J., and Lyne M. The quality of Health care in prison: Results of a year's programme of semistructured inspections. British Medical Journal 315 7120 (1997) 1420-1424
64. Seaman S.R., Brettle R.P., and Gore S.M. Mortality from overdose among injecting drug users recently released from prison: Database linkage study. British Medical Journal 316 (1998) 426-428
65. Sees K.L., Delucchi K.L., Masson C., Rosen A., Clark H.W., Robillard H., et al. Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: A randomized controlled trial. Journal of American Medical Association 283 10 (2000) 1303-1310
66. Seymour A., Oliver J.S., and Black M. Drug-related deaths among recently released prisoners in the Strathclyde Region of Scotland. Journal of Forensic Sciences 45 3 (2000) 649-654
67. Shewan D., Gemmel M., and Davies J.B. Prison as a modifier of drug using behaviour. Addiction Research 2 2 (1994) 203-215
68. Shewan D., Reid M., MacPherson S., Davies J.B., and Greenwood J. Injecting risk behaviour among recently released prisoners in Edinburgh (Scotland): The impact of in-prison and community drug treatment services. Legal and Criminological Psychology 6 (2001) 19-28
69. Shewan, D., Stöver, H., & Dolan, K. (2005). Injecting in Prisons-UK, Germany and Australia. In R. Pates & J. Wichter (Ed.), 'Injecting illicit drugs'.
70. Sibbald B. Methadone maintenance expands inside federal prisons. Canadian Medical Association Journal 167 10 (November 12, 2002) 1154
71. Singleton N., Pendry E., Taylor C., Farrell M., and Marsden J. Drug-related mortality among newly released offenders (2003), Home Office, London
72. Sorensen J.L., and Copeland A.L. Drug abuse treatment as an HIV prevention strategy: A review. Drug & Alcohol Dependence 59 1 (2000) 17-31
73. Stöver H., Hennebel L.C., and Casselman J. Substitution treatment in European prisons. A study of policies and practices of substitution treatment in prisons in 18 European countries (2004), Cranstoun Drug Services, London
74. Strain E.C., Bigelow G.E., Liebson I.A., and Stitzer M.L. Moderate- vs. high-dose methadone in the treatment of opioid dependence: A randomized trial. Journal of American Medical Association 281 11 (1999) 1000-1005
75. Taylor A., Champion J., and Fleming A. The role of methadone maintenance in Scottish prisons: Prisoners' perspectives (2006), Scottish Prison Service, Institute for Applied Social and Health Research, University of Paisley, NHS Greater Glasgow
76. The Australian (April 17, 2006). Methadone for prisoners 'saves money'.
77. UNAIDS, United Nations Office on Drugs and Crime (UNODC), World Health Organization (WHO) (2004). Substitution maintenance therapy in the management of opioid dependence and HIV/AIDS prevention: Position paper.
78. Vanichseni S., Wongsuwan B., Choopanya K., and Wongpanich K. A controlled trial of methadone maintenance in a population of intravenous drug users in Bangkok: Implications for prevention of HIV. International Journal of Addiction 26 12 (1991) 1313-1320
79. Verger P., Rotily M., Prudhomme J., and Bird S. High mortality rates among inmates during the year following their discharge from a French prison. Journal of Forensic Sciences 48 3 (2003) 614-616
80. Washton A.M., Resnick R.B., and Geyer G. Substance misuse among prisoners. Office of National Statistics (1983), The Stationary Office, London
81. Wale, S., & Gorta, A. (1987). Views of inmates participating in the pilot pre-release methadone programme. Publication No. 2. Research and Statistics Division: NSW Department of Corrective Services.
82. Ward J., Mattick R., and Hall W. Key issues in methadone maintenance treatment (1992), University of New South Wales Press, Sydney
83. Ward J., Mattick R.P., and Hall W. The use of methadone during maintenance treatment: Pharmacology, dosage and treatment outcome. In: Ward J., Mattick R.P., and Hall W. (Eds). Methadone maintenance treatment and other opioid replacement therapies (1998), Harwood Academic Publishers, Amsterdam 205-238
84. Wood E., Lim R., and Kerr T. Initiation of opiate addiction in a Canadian prison: A case report. Harm Reduction Journal 3 (2006) 11. http://www.harmreductionjournal.com/content/3/1/11 http://www.harmreductionjournal.com/content/3/1/11; May 26, 2006
85. World Health Organization/WHO. Guidelines of HIV and AIDS in prisons (1993), WHO, Geneva/Switzerland
86. World Health Organization/WHO. Evidence for action technical papers. Effectiveness of drug dependence treatment in preventing HIV among injecting drug users (2005), WHO, Geneva/Switzerland
87. Zador D., Sunjic S., and Darke S. Heroin related deaths in New South Wales, 1992: Toxicological findings and circumstances. Medical Journal of Australia 164 (1996) 204-207
88. Zangerle R., Fuchs D., Rossler H., Reibnegger G., Riemer Y., Weiss S.H., et al. Trends in HIV infection among intravenous drug users in Innsbruck, Austria. Journal of Acquired Immune Deficiency Syndromes 5 9 (1992) 865-871